Infections caused by fusarium species in pediatric cancer patients and review of published literature

被引:28
作者
Arnoni M.V. [1 ]
Paula C.R. [2 ]
Auler M.E. [3 ]
Simões C.C.N. [1 ]
Nakano S. [1 ]
Szeszs M.W. [4 ]
Melhem M.D.S.C. [4 ]
Pereira V.B.R. [5 ]
Garces H.G. [6 ]
Bagagli E. [6 ]
Silva E.G. [2 ]
De Macêdo M.F. [1 ]
Da Silva Ruiz L. [5 ]
机构
[1] Hospital Infantil Darcy Vargas, São Paulo, SP
[2] Faculdade de Odontologia, Universidade de São Paulo (USP), São Paulo, SP
[3] Departamento de Farmácia, Universidade Estadual do Centro-Oeste do Paraná (UNICENTRO), Guarapuava, PR
[4] Seção de Micologia, Instituto Adolfo Lutz (IAL), São Paulo, SP
[5] Núcleo de Ciências Biomédicas, Instituto Adolfo Lutz (IAL), CLR II, Bauru, SP
[6] Departamento de Microbiologia e Imunologia, Universidade Estadual Paulista (UNESP), Botucatu, SP
关键词
Cancer; Children; Fusarium spp; Nosocomial infection;
D O I
10.1007/s11046-018-0257-6
中图分类号
学科分类号
摘要
Fusarium species have emerged as responsible for a broad spectrum of infections, including superficial, locally invasive and disseminated ones, especially in the hospital environment. Since there are few reports of invasive and disseminated fusariosis in children, the aim of this study was to report four cases of nosocomial infection caused by this microorganism in children with cancer hospitalized in a public children’s hospital located in Brazil. Two of these patients were female and two were male. All patients presented febrile neutropenia, while three patients had acute lymphocytic leukemia and one patient had Wilms’ tumor as underlying disease. In two cases, fungi were isolated from blood and identified as Fusarium oxysporum species complex after phenotypic and genotypic studies, while in two other cases fungi were isolated from skin biopsies and identified as Fusarium solani species complex. One patient died 12 days after the onset of cutaneous lesions. All isolates, after susceptibility testing, presented high levels of minimum inhibitory concentration for itraconazole, voriconazole and amphotericin B. Considering the emergence of filamentous fungi as etiologic agents of nosocomial infections, health professionals should be aware of the problems these infections, especially fungal ones, may cause to debilitated patients. © Springer Science+Business Media B.V., part of Springer Nature 2018.
引用
收藏
页码:941 / 949
页数:8
相关论文
共 51 条
[1]  
Tragiannidis A., Dokos C., Sidi V., Papageorgiou T., Koliouskas D., Karamouzis M., Et al., Alterations of bone mineral metabolism of children with different cell lineage types of acute lymphoblastic leukaemia under chemotherapy, Hippokratia, 15, pp. 43-47, (2011)
[2]  
Georgiadou S.P., Pongas G., Fitzgerald N.E., Lewis R.E., Rytting M., Marom E.M., Et al., Invasive mold infections in pediatric cancer patients reflect heterogeneity in etiology, presentation, and outcome: A 10-year, single-institution, retrospective study, J Pediatr Infect Dis Soc, 1, pp. 125-135, (2012)
[3]  
Nucci M., Anaissie E., Fusarium infections in immunocompromised patients, Clin Microbiol Rev, 20, pp. 695-704, (2007)
[4]  
Guarro J., Fusarium, a complex infection caused by a high diversity of fungal species refractory to treatment, Eur J Clin Microbiol Infect Dis, 32, pp. 1491-1500, (2013)
[5]  
Muhammed M., Anagnostou T., Desalermos A., Kourkoumpetis T.K., Carneiro H.A., Glavis-Bloom J., Et al., Fusarium infection: Report of 26 cases and review of 97 cases from the literature, Medicine, 92, pp. 305-316, (2013)
[6]  
Tortorano A.M., Prigitano A., Esposto M.C., Arsic Arsenijevic V., Kolarovic J., Ivanovic D., Et al., ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp and others, Clin Microbiol Infect, 20, pp. 27-46, (2014)
[7]  
Boutati E.I., Anaissie J., Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years’ experience at a cancer center and implications for management, Blood, 90, pp. 999-1008, (1997)
[8]  
Nucci M., Anaissie J., Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: Implications for diagnosis and management, Clin Infect Dis J, 35, pp. 909-920, (2002)
[9]  
Van Diepeningen A.D., Brankovics B., Iltes J., Van Der Lee T.A., Waalwijk C., Diagnosis of Fusarium infections: Approaches to identification by the clinical mycology laboratory, Curr Fungal Infect Rep, 9, 3, pp. 135-143, (2015)
[10]  
Nucci M., Anaissie E.J., Queiroz-Telles F., Martins C.A., Trabasso P., Solza C., Et al., Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection, Cancer, 98, pp. 315-319, (2003)